Therapeutic molecules for modulation stability of VEGF transcripts

Details for Australian Patent Application No. 2011203348 (hide)

Owner Lions Eye Institute Limited

Inventors Rakoczy, Elizabeth Piroska; Marano, Robert Jeffery

Agent Davies Collison Cave

Pub. Number AU-A-2011203348

Parent 2005229159

Filing date 7 July 2011

Wipo publication date 4 August 2011

International Classifications

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/18 (2006.01) Mutation or genetic engineering

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

28 July 2011 Complete Application Filed

4 August 2011 Application Open to Public Inspection

  Published as AU-A-2011203348

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203349-HCV NS-3 serine protease inhibitors

2011203347-Compositions and methods for the treatment of tumor of hematopoietic origin